Risperdal approved for use in children
August 24, 2007
Studies by Johnson & Johnson found that a higher Risperdal dose was no more effective than a lower one in children and that information will be included on the drug’s label.
The FDA approval comes with important information for doctors about dosing and side effects.
Researchers found that side effects in the pediatric studies were similar to those experienced in adults and included drowsiness, fatigue, increase in appetite, anxiety, nausea, dizziness, dry mouth, tremor and rashes.
Before the FDA granted Risperdal this approval, Lithium was the only approved drug for treating bipolar disorder in adolescents 12 years old and up.
Comments
Got something to say?
Powered by WordPress
